Covid-19 Impact on Antifungal Drug Market , Global Research Reports 2020-2021

1.2 Market Segmentation

1.3 Research Objectives

1.4 Research Methodology

1.4.1 Research Process

1.4.2 Data Triangulation

1.4.3 Research Approach

1.4.4 Base Year

1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

1.5.2 Covid-19 Impact: Commodity Prices Indices

1.5.3 Covid-19 Impact: Global Major Government Policy

1.6 The Covid-19 Impact on Antifungal Drug Industry

1.7 COVID-19 Impact: Antifungal Drug Market Trends

2 Global Antifungal Drug Quarterly Market Size Analysis

2.1 Antifungal Drug Business Impact Assessment - COVID-19

2.1.1 Global Antifungal Drug Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.1.2 Global Antifungal Drug Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.2 Global Antifungal Drug Quarterly Market Size 2020-2021

2.3 COVID-19-Driven Market Dynamics and Factor Analysis

2.3.1 Drivers

2.3.2 Restraints

2.3.3 Opportunities

2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

3.1 Global Antifungal Drug Quarterly Market Size by Manufacturers, 2019 VS 2020

3.2 Global Antifungal Drug Factory Price by Manufacturers

3.3 Location of Key Manufacturers Antifungal Drug Manufacturing Factories and Area Served

3.4 Date of Key Manufacturers Enter into Antifungal Drug Market

3.5 Key Manufacturers Antifungal Drug Product Offered

3.6 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Antifungal Drug Segments, By Type

4.1 Introduction

1.4.1 Echinocandins

1.4.2 Azoles

1.4.3 Ployenes

1.4.4 Allylamines

4.2 By Type, Global Antifungal Drug Market Size, 2019-2021

4.2.1 By Type, Global Antifungal Drug Market Size by Type, 2020-2021

4.2.2 By Type, Global Antifungal Drug Price, 2020-2021

5 Impact of Covid-19 on Antifungal Drug Segments, By Application

5.1 Overview

5.5.1 Aspergillosis

5.5.2 Dermatophytosis

5.5.3 Candidiasis

5.2 By Application, Global Antifungal Drug Market Size, 2019-2021

5.2.1 By Application, Global Antifungal Drug Market Size by Application, 2019-2021

5.2.2 By Application, Global Antifungal Drug Price, 2020-2021

6 Geographic Analysis

6.1 Introduction

6.2 North America

6.2.1 Macroeconomic Indicators of US

6.2.2 US

6.2.3 Canada

6.3 Europe

6.3.1 Macroeconomic Indicators of Europe

6.3.2 Germany

6.3.3 France

6.3.4 UK

6.3.5 Italy

6.4 Asia-Pacific

6.4.1 Macroeconomic Indicators of Asia-Pacific

6.4.2 China

6.4.3 Japan

6.4.4 South Korea

6.4.5 India

6.4.6 ASEAN

6.5 Rest of World

6.5.1 Latin America

6.5.2 Middle East and Africa

7 Company Profiles

7.1 Asperqillus

7.1.1 Asperqillus Business Overview

7.1.2 Asperqillus Antifungal Drug Quarterly Production and Revenue, 2020

7.1.3 Asperqillus Antifungal Drug Product Introduction

7.1.4 Asperqillus Response to COVID-19 and Related Developments

7.2 Alternaria

7.2.1 Alternaria Business Overview

7.2.2 Alternaria Antifungal Drug Quarterly Production and Revenue, 2020

7.2.3 Alternaria Antifungal Drug Product Introduction

7.2.4 Alternaria Response to COVID-19 and Related Developments

7.3 Abbott Laboratories

7.3.1 Abbott Laboratories Business Overview

7.3.2 Abbott Laboratories Antifungal Drug Quarterly Production and Revenue, 2020

7.3.3 Abbott Laboratories Antifungal Drug Product Introduction

7.3.4 Abbott Laboratories Response to COVID-19 and Related Developments

7.4 Pfizer

7.4.1 Pfizer Business Overview

7.4.2 Pfizer Antifungal Drug Quarterly Production and Revenue, 2020

7.4.3 Pfizer Antifungal Drug Product Introduction

7.4.4 Pfizer Response to COVID-19 and Related Developments

7.5 Glaxosmithkline

7.5.1 Glaxosmithkline Business Overview

7.5.2 Glaxosmithkline Antifungal Drug Quarterly Production and Revenue, 2020

7.5.3 Glaxosmithkline Antifungal Drug Product Introduction

7.5.4 Glaxosmithkline Response to COVID-19 and Related Developments

7.6 Bayer Healthcare

7.6.1 Bayer Healthcare Business Overview

7.6.2 Bayer Healthcare Antifungal Drug Quarterly Production and Revenue, 2020

7.6.3 Bayer Healthcare Antifungal Drug Product Introduction

7.6.4 Bayer Healthcare Response to COVID-19 and Related Developments

7.7 Novartis

7.7.1 Novartis Business Overview

7.7.2 Novartis Antifungal Drug Quarterly Production and Revenue, 2020

7.7.3 Novartis Antifungal Drug Product Introduction

7.7.4 Novartis Response to COVID-19 and Related Developments

7.8 Sanofi-Aventis

7.8.1 Sanofi-Aventis Business Overview

7.8.2 Sanofi-Aventis Antifungal Drug Quarterly Production and Revenue, 2020

7.8.3 Sanofi-Aventis Antifungal Drug Product Introduction

7.8.4 Sanofi-Aventis Response to COVID-19 and Related Developments

7.9 Merck & Co.

7.9.1 Merck & Co. Business Overview

7.9.2 Merck & Co. Antifungal Drug Quarterly Production and Revenue, 2020

7.9.3 Merck & Co. Antifungal Drug Product Introduction

7.9.4 Merck & Co. Response to COVID-19 and Related Developments

7.10 Kramer Laboratories

7.10.1 Kramer Laboratories Business Overview

7.10.2 Kramer Laboratories Antifungal Drug Quarterly Production and Revenue, 2020

7.10.3 Kramer Laboratories Antifungal Drug Product Introduction

7.10.4 Kramer Laboratories Response to COVID-19 and Related Developments

7.11 Enzon Pharmaceuticals

7.11.1 Enzon Pharmaceuticals Business Overview

7.11.2 Enzon Pharmaceuticals Antifungal Drug Quarterly Production and Revenue, 2020

7.11.3 Enzon Pharmaceuticals Antifungal Drug Product Introduction

7.11.4 Enzon Pharmaceuticals Response to COVID-19 and Related Developments

7.12 Gilead

7.12.1 Gilead Business Overview

7.12.2 Gilead Antifungal Drug Quarterly Production and Revenue, 2020

7.12.3 Gilead Antifungal Drug Product Introduction

7.12.4 Gilead Response to COVID-19 and Related Developments

8 Supply Chain and Sales Channels Analysis

8.1 Antifungal Drug Supply Chain Analysis

8.1.1 Antifungal Drug Supply Chain Analysis

8.1.2 Covid-19 Impact on Antifungal Drug Supply Chain

8.2 Distribution Channels Analysis

8.2.1 Antifungal Drug Distribution Channels

8.2.2 Covid-19 Impact on Antifungal Drug Distribution Channels

8.2.3 Antifungal Drug Distributors

8.3 Antifungal Drug Customers

9 Key Findings

10 Appendix

10.1 About Us

10.2 Disclaimer

Table 1. Overview of the World Economic Outlook Projections

Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 7. Covid-19 Impact: Global Major Government Policy

Table 8. The Covid-19 Impact on Antifungal Drug Assessment

Table 9. COVID-19 Impact: Antifungal Drug Market Trends

Table 10. COVID-19 Impact Global Antifungal Drug Market Size

Table 11. Global Antifungal Drug Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)

Table 12. Global Antifungal Drug Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)

Table 13. Global Antifungal Drug Quarterly Market Size, 2020 (US$ Million) & (K Units)

Table 14. Global Antifungal Drug Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)

Table 15. Global Antifungal Drug Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)

Table 16. Global Antifungal Drug Market Growth Drivers

Table 17. Global Antifungal Drug Market Restraints

Table 18. Global Antifungal Drug Market Opportunities

Table 19. Global Antifungal Drug Market Challenges

Table 20. Key Manufacturers Antifungal Drug Quarterly Revenue, 2019 VS 2020 (US$ Million)

Table 21. Top Manufacturers, Antifungal Drug Market Size, 2019 (K Units) & (US$ Million)

Table 22. Antifungal Drug Factory Price by Manufacturers 2020 (USD/Unit)

Table 23. Location of Key Manufacturers Antifungal Drug Manufacturing Plants

Table 24. Key Manufacturers Antifungal Drug Market Served

Table 25. Date of Key Manufacturers Enter into Antifungal Drug Market

Table 26. Key Manufacturers Antifungal Drug Product Type

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Antifungal Drug Market Size by Type, 2020, (US$ Million)

Table 29. Global Antifungal Drug Market Size by Type, 2020 (K Units)

Table 30. Global Antifungal Drug Price: by Type, 2020-2021 (USD/Unit)

Table 31. Global Antifungal Drug Market Size by Application: 2020-2021 (US$ Million)

Table 32. Global Antifungal Drug Market Size by Application, 2020-2021 (K Units)

Table 33. Global Antifungal Drug Price: by Application, 2020-2021 (USD/Unit)

Table 34. Global Antifungal Drug Market Size by Region, 2019-2021 (US$ Million)

Table 35. Global Antifungal Drug Market Size by Region, 2019-2021 (K Units)

Table 36. By Country, North America Antifungal Drug Market Size, 2019-2021 (US$ Million)

Table 37. By Country, North America Antifungal Drug Market Size, 2019-2021 (K Units)

Table 38. US Antifungal Drug Market Size, 2019-2021 (US$ Million) & (K Units)

Table 39. Canada Antifungal Drug Market Size, 2019-2021 (US$ Million) & (K Units)

Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)

Table 41. By Country, Europe Antifungal Drug Market Size, 2019-2021 (US$ Million)

Table 42. By Country, Europe Antifungal Drug Market Size, 2019-2021 (K Units)

Table 43. Germany Antifungal Drug Market Size, 2019-2021 (US$ Million) & (K Units)

Table 44. France Antifungal Drug Market Size, 2019-2021 (US$ Million) & (K Units)

Table 45. UK Antifungal Drug Market Size, 2019-2021 (US$ Million) & (K Units)

Table 46. Italy Antifungal Drug Market Size, 2019-2021 (US$ Million) & (K Units)

Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)

Table 48. By Region, Asia-Pacific Antifungal Drug Market Size, 2019-2021 (US$ Million)

Table 49. By Region, Asia-Pacific Antifungal Drug Market Size, 2019-2021 (K Units)

Table 50. China Antifungal Drug Market Size, 2019-2021 (US$ Million) & (K Units)

Table 51. Japan Antifungal Drug Market Size, 2019-2021 (US$ Million) & (K Units)

Table 52. South Korea Antifungal Drug Market Size, 2019-2021 (US$ Million) & (K Units)

Table 53. India Antifungal Drug Market Size, 2019-2021 (US$ Million) & (K Units)

Table 54. ASEAN Antifungal Drug Market Size, 2019-2021 (US$ Million) & (K Units)

Table 55. Latin America Antifungal Drug Market Size, 2019-2021 (US$ Million) & (K Units)

Table 56. Middle East and Africa Antifungal Drug Market Size, 2019-2021 (US$ Million) & (K Units)

Table 57. Asperqillus Business Overview

Table 58. Asperqillus Antifungal Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 59. Asperqillus Antifungal Drug Product

Table 60. Asperqillus Response to COVID-19 and Related Developments

Table 61. Alternaria Business Overview

Table 62. Alternaria Antifungal Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 63. Alternaria Antifungal Drug Product

Table 64. Alternaria Response to COVID-19 and Related Developments

Table 65. Abbott Laboratories Business Overview

Table 66. Abbott Laboratories Antifungal Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 67. Abbott Laboratories Antifungal Drug Product

Table 68. Abbott Laboratories Response to COVID-19 and Related Developments

Table 69. Pfizer Business Overview

Table 70. Pfizer Antifungal Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 71. Pfizer Antifungal Drug Product

Table 72. Pfizer Response to COVID-19 and Related Developments

Table 73. Glaxosmithkline Business Overview

Table 74. Glaxosmithkline Antifungal Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 75. Glaxosmithkline Antifungal Drug Product

Table 76. Glaxosmithkline Response to COVID-19 and Related Developments

Table 77. Bayer Healthcare Business Overview

Table 78. Bayer Healthcare Antifungal Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 79. Bayer Healthcare Antifungal Drug Product

Table 80. Bayer Healthcare Response to COVID-19 and Related Developments

Table 81. Novartis Business Overview

Table 82. Novartis Antifungal Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 83. Novartis Antifungal Drug Product

Table 84. Novartis Response to COVID-19 and Related Developments

Table 85. Sanofi-Aventis Business Overview

Table 86. Sanofi-Aventis Antifungal Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 87. Sanofi-Aventis Antifungal Drug Product

Table 88. Sanofi-Aventis Response to COVID-19 and Related Developments

Table 89. Merck & Co. Business Overview

Table 90. Merck & Co. Antifungal Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 91. Merck & Co. Antifungal Drug Product

Table 92. Merck & Co. Response to COVID-19 and Related Developments

Table 93. Kramer Laboratories Business Overview

Table 94. Kramer Laboratories Antifungal Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 95. Kramer Laboratories Antifungal Drug Product

Table 96. Kramer Laboratories Response to COVID-19 and Related Developments

Table 97. Enzon Pharmaceuticals Business Overview

Table 98. Enzon Pharmaceuticals Antifungal Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 99. Enzon Pharmaceuticals Antifungal Drug Product

Table 100. Enzon Pharmaceuticals Response to COVID-19 and Related Developments

Table 101. Gilead Business Overview

Table 102. Gilead Antifungal Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 103. Gilead Antifungal Drug Product

Table 104. Gilead Response to COVID-19 and Related Developments

Table 105. Antifungal Drug Distributors List

Table 106. Antifungal Drug Customers List

Table 107. Covid-19 Impact on Antifungal Drug Customers

List of Figures

Figure 1. Antifungal Drug Product Picture

Figure 2. Antifungal Drug Market Segmentation

Figure 3. Research Objectives

Figure 4. Research Process

Figure 5. Data Triangulation

Figure 6. Research Approach

Figure 7. Commodity Prices-Metals Price Indices

Figure 8. Commodity Prices- Precious Metal Price Indices

Figure 9. Commodity Prices- Agricultural Raw Material Price Indices

Figure 10. Commodity Prices- Food and Beverage Price Indices

Figure 11. Commodity Prices- Fertilizer Price Indices

Figure 12. Commodity Prices- Energy Price Indices

Figure 13. G20+: Economic Policy Responses to COVID-19

Figure 14. Global Antifungal Drug Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)

Figure 15. Global Antifungal Drug Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)

Figure 16. Global Antifungal Drug Market Size, Quarterly Growth, 2020-2021 (%)

Figure 17. Global Antifungal Drug Market Size, Market Share by Type, 2019 VS 2020 (%)

Figure 18. Global Antifungal Drug Market Size, Market Share by Application, 2019 VS 2020 (%)

Figure 19. Global Antifungal Drug Market Size Market Share by Region, 2019 VS 2020 (%)

Figure 20. United States Composite PMI and GDP

Figure 21. Eurozone Composite PMI and GDP

Figure 22. Eurozone Core v. Periphery PMI Output Indices

Figure 23. Core v. Periphery PMI Employment Indices

Figure 24. UK Composite PMI and GDP

Figure 25. Caixin China Composite Output Index

Figure 26. Caixin China General Services Business Activity Index

Figure 27. Japan Composite Output Index

Figure 28. South Korea Manufacturing PMI

Figure 29. India Composite Output Index

Figure 30. ASEAN Manufacturing PMI

Figure 31. By Region, Asia-Pacific Antifungal Drug Market Size Market Share, 2019-2021